Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2025 Filed Mar 13, 2026 01:31 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 75.256 | $166.10 | $12,500.02 |
DisclosureSEC source: 0000200406-26-000070 · wk-form4_1773365486.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,306.4487 Underlying: Common Stock · 75.256 shares Expires not disclosed F1 · derivative.exercise_price: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F1 · derivative.exercise_date: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F1 · derivative.expiration_date: Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 23:42 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 6,999 | $101.87 Strike: $101.87 | $712,988.13 |
DisclosureSEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,999 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vested and exercisable on the third anniversary of the date of the grant. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 23:42 UTC |
Decker Robert JVP Corporate Controller
|
SaleCommon Stock | 6,999 | $165.88 | $1,160,994.12 |
DisclosureSEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,001 F1 · price: This transaction was executed in multiple trades at prices ranging from $165.88 to $165.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 23:42 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 6,999 | $101.87 | $712,988.13 |
DisclosureSEC source: 0000200406-25-000086 · wk-form4_1740613359.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 01:58 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Tax withholdingCommon Stock | 158 | $156.15 | $24,671.70 |
DisclosureSEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · nonDerivative · entry 6 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,681 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:01 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 94 | $156.15 | $14,678.10 |
DisclosureSEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · nonDerivative · entry 6 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,022 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:02 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 1,602 | $156.15 | $250,152.30 |
DisclosureSEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · nonDerivative · entry 6 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,923 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:03 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Tax withholdingCommon Stock | 307 | $156.15 | $47,938.05 |
DisclosureSEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · nonDerivative · entry 6 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,014 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:05 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 120 | $156.15 | $18,738.00 |
DisclosureSEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · nonDerivative · entry 6 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,975 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Tax withholdingCommon Stock | 141 | $156.15 | $22,017.15 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 6 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,620.59 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 651 | $156.15 | $101,653.65 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 6 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,459.001 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:11 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Tax withholdingCommon Stock | 385 | $156.15 | $60,117.75 |
DisclosureSEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · nonDerivative · entry 2 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 768 | $156.15 | $119,923.20 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,345 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 200 | $156.15 | $31,230.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 6 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,836.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
SaleCommon Stock | 403 | $156.15 | $62,928.45 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 6 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,098 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 01:58 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · derivative · entry 12 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 983 Underlying: Common Stock · 492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 01:58 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000040 · wk-form4_1739930299.xml · nonDerivative · entry 5 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under the Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:01 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · derivative · entry 13 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 677 Underlying: Common Stock · 339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:01 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000042 · wk-form4_1739930459.xml · nonDerivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:02 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · derivative · entry 12 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,364 Underlying: Common Stock · 3,682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:02 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000044 · wk-form4_1739930549.xml · nonDerivative · entry 5 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:03 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · derivative · entry 11 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,922 Underlying: Common Stock · 961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:03 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000046 · wk-form4_1739930611.xml · nonDerivative · entry 5 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:05 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · derivative · entry 11 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:05 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000048 · wk-form4_1739930704.xml · nonDerivative · entry 5 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionRestricted Share Units · Derivative | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · derivative · entry 11 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 983 Underlying: Common Stock · 492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:06 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000050 · wk-form4_1739930786.xml · nonDerivative · entry 5 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,761.59 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · derivative · entry 11 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,188 Underlying: Common Stock · 1,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:08 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000052 · wk-form4_1739930875.xml · nonDerivative · entry 5 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,110.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:11 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionRestricted Share Units · Derivative | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · derivative · entry 3 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,698 Underlying: Common Stock · 1,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F3 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:11 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000054 · wk-form4_1739931099.xml · nonDerivative · entry 1 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · derivative · entry 13 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,942 Underlying: Common Stock · 1,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:13 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000056 · wk-form4_1739931179.xml · nonDerivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionRestricted Share Units · Derivative | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · derivative · entry 13 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:16 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000058 · wk-form4_1739931408.xml · nonDerivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,036.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 9 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,056 Underlying: Common Stock · 1,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:33 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:16 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantRestricted Share Units · Derivative | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000064 · wk-form4_1740003385.xml · derivative · entry 2 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,576 Underlying: Common Stock · 1,576 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:16 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 25,538 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000064 · wk-form4_1740003385.xml · derivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,538 Underlying: Common Stock · 25,538 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:18 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantRestricted Share Units · Derivative | 13,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000066 · wk-form4_1740003520.xml · derivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,513 Underlying: Common Stock · 13,513 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:18 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 219,020 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000066 · wk-form4_1740003520.xml · derivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,020 Underlying: Common Stock · 219,020 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:22 UTC |
Decker Robert JVP Corporate Controller
|
GrantRestricted Share Units · Derivative | 1,031 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000068 · wk-form4_1740003766.xml · derivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,031 Underlying: Common Stock · 1,031 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:22 UTC |
Decker Robert JVP Corporate Controller
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 8,357 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000068 · wk-form4_1740003766.xml · derivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,357 Underlying: Common Stock · 8,357 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:25 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
GrantRestricted Share Units · Derivative | 3,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000070 · wk-form4_1740003921.xml · derivative · entry 2 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,189 Underlying: Common Stock · 3,189 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:25 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 51,688 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000070 · wk-form4_1740003921.xml · derivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,688 Underlying: Common Stock · 51,688 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:27 UTC |
Mulholland KristenEVP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000072 · wk-form4_1740004038.xml · derivative · entry 2 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,725 Underlying: Common Stock · 1,725 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:27 UTC |
Mulholland KristenEVP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 27,951 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000072 · wk-form4_1740004038.xml · derivative · entry 1 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,951 Underlying: Common Stock · 27,951 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:29 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantRestricted Share Units · Derivative | 5,539 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000074 · wk-form4_1740004157.xml · derivative · entry 2 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,539 Underlying: Common Stock · 5,539 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:29 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 89,781 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000074 · wk-form4_1740004157.xml · derivative · entry 1 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,781 Underlying: Common Stock · 89,781 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:31 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
GrantRestricted Share Units · Derivative | 3,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000076 · wk-form4_1740004292.xml · derivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,077 Underlying: Common Stock · 3,077 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.